Press "Enter" to skip to content

TYME Presented Updated Data at ESMO 2019 from SM-88 Phase II Prostate Cancer Study Demonstrating Encouraging Clinical Benefit in Patients with Recurrent Prostate Cancer – GlobeNewswire

admin 0

TYME Presented Updated Data at ESMO 2019 from SM-88 Phase II Prostate Cancer Study Demonstrating Encouraging Clinical Benefit in Patients with Recurrent Prostate Cancer  GlobeNewswire
“prostate cancer” – Google News

(Visited 6 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *